SM16, an Orally Active TGF-β Type I Receptor Inhibitor Prevents Myofibroblast Induction and Vascular Fibrosis in the Rat Carotid Injury Model

Kai Fu(Norwegian Womens Public Health Association), Leona Ling(Norwegian Womens Public Health Association)
Arteriosclerosis Thrombosis and Vascular Biology
January 18, 2008
10.1161/atvbaha.107.158030
Cited by 84

Related Papers

No related papers found

Powered by citation graph analysis